Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: Expression frequency and their correlation with clinical parameters

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 8, 2013, Pages 1610-1616

  Xia, Qiu Yuan ^a   Liu, Song ^b   Li Dr , Fang Qiu ^b   Huang, Wen Bin ^c   Shi, Li Ning ^b   Zhou, Xiao Jun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer testis antigens; Hepatocellular carcinoma; MAGE C1; NY ESO 1; Sp17

Indexed keywords

CARRIER PROTEIN; CTAG1B PROTEIN, HUMAN; MAGEC1 PROTEIN, HUMAN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; SPA17 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CANCER-TESTIS ANTIGENS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; MAGE-C1; MALE; METABOLISM; NY-ESO-1; PATHOLOGY; SP17;

CANCER-TESTIS ANTIGENS; HEPATOCELLULAR CARCINOMA; MAGE-C1; NY-ESO-1; SP17;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84882983979     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jaskiewicz K, Stepien A and Banach L. Hepatocellular carcinoma in a rural population at risk. Anticancer Res 1991; 11: 2187-2189.
2. Zerbini A, Pilli M, Ferrari C and Missale G. Is there a role for immunotherapy in hepatocellular carcinoma? Dig Liver Dis 2006; 38: 221-225.
3. Marrero JA. Hepatocellular carcinoma. Curr Opin Gastroenterol 2006; 22: 248-253.
4. Motola-Kuba D, Zamora-Valdes D, Uribe M and Mendez-Sanchez N. Hepatocellular carcinoma. An overview. Ann Hepatol 2006; 5: 16-24.
5. Siegel R, Ward E, Brawley O and Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
6. Farazi PA and DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-687.
7. Abelev GI. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res 1968; 28: 1344-1350.
8. Daniele B, Bencivenga A, Megna AS and Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004; 127: S108-112.
9. Zhou L, Liu J and Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12: 1175-1181.
10. Yuen MF and Lai CL. Serological markers of liver cancer. Best Pract Res Clin Gastroenterol 2005; 19: 91-99.
11. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ and Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32.
12. Li FQ, Han YL, Liu Q, Wu B, Huang WB and Zeng SY. Overexpression of human sperm protein 17 increases migration and decreases the chemosensitivity of human epithelial ovarian cancer cells. BMC Cancer 2009; 9: 323.
13. Li FQ, Liu Q, Han YL, Wu B and Yin HL. Sperm protein 17 is highly expressed in endometrial and cervical cancers. BMC Cancer 2010; 10: 429.
14. Kawada J, Wada H, Isobe M, Gnjatic S, Nishikawa H, Jungbluth AA, Okazaki N, Uenaka A, Nakamura Y, Fujiwara S, Mizuno N, Saika T, Ritter E, Yamasaki M, Miyata H, Ritter G, Murphy R, Venhaus R, Pan L, Old LJ, Doki Y and Nakayama E. Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination. Int J Cancer 2012; 130: 584-592.
15. Matkovic B, Juretic A, Spagnoli GC, Separovic V, Gamulin M, Separovic R, Saric N, Basic-Koretic M, Novosel I and Kruslin B. Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study. Croat Med J 2011; 52: 171-177.
16. Richardson RT, Yamasaki N and O'Rand MG. Sequence of a rabbit sperm zona pellucida binding protein and localization during the acrosome reaction. Dev Biol 1994; 165: 688-701.
17. Kong M, Richardson RT, Widgren EE and O'Rand MG. Sequence and localization of the mouse sperm autoantigenic protein, Sp17. Biol Reprod 1995; 53: 579-590.
18. Lea IA, Kurth B and O'Rand MG. Immune response to immunization with sperm antigens in the macaque oviduct. Biol Reprod 1998; 58: 794-800.
19. Dong G, Loukinova E, Smith CW, Chen Z and Van Waes C. Genes differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma. J Cell Biochem Suppl 1997; 28-29: 90-100.
20. Lim SH, Wang Z, Chiriva-Internati M and Xue Y. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood 2001; 97: 1508-1510.
21. Straughn JM Jr, Shaw DR, Guerrero A, Bhoola SM, Racelis A, Wang Z, Chiriva-Internati M, Grizzle WE, Alvarez RD, Lim SH and Strong TV. Expression of sperm protein 17 (Sp17) in ovarian cancer. Int J Cancer 2004; 108: 805-811.
22. Grizzi F, Gaetani P, Franceschini B, Di Ieva A, Colombo P, Ceva-Grimaldi G, Bollati A, Frezza EE, Cobos E, Rodriguez y Baena R, Dioguardi N and Chiriva-Internati M. Sperm protein 17 is expressed in human nervous system tumours. BMC Cancer 2006; 6: 23.
23. Nakazato T, Kanuma T, Tamura T, Faried LS, Aoki H and Minegishi T. Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer. Int J Gynecol Cancer 2007; 17: 426-432.
24. McLeskey SB, Dowds C, Carballada R, White RR and Saling PM. Molecules involved in mammalian sperm-egg interaction. Int Rev Cytol 1998; 177: 57-113.
25. Zhao L, Mou DC, Leng XS, Peng JR, Wang WX, Huang L, Li S and Zhu JY. Expression of cancer-testis antigens in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 2034-2038.
26. Wu LQ, Lu Y, Wang XF, Lv ZH, Zhang B and Yang JY. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma. Life Sci 2006; 79: 744-748.
27. Peng JR, Chen HS, Mou DC, Cao J, Cong X, Qin LL, Wei L, Leng XS, Wang Y and Chen WF. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters. Cancer Lett 2005; 219: 223-232.
28. Wang XY, Chen HS, Luo S, Zhang HH, Fei R and Cai J. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues. Oncol Rep 2009; 21: 713-719.
29. Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E and Shiratori Y. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma. J Gastroenterol Hepatol 2006; 21: 1281-1285.
30. Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP and Greten TF. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res 2004; 10: 4332-4341.
31. Peck-Radosavljevic M, Pidlich J, Bergmann M, Ferenci P, Seelos C, Wichlas M, Lipinski E, Gnant M, Gangl A and Muhlbacher F. Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group. J Hepatol 1998; 28: 497-503.
32. Lee KD, Chang HK, Jo YK, Kim BS, Lee BH, Lee YW, Lee HK, Huh MH, Min YG, Spagnoli GC and Yu TH. Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck. Anticancer Res 1999; 19: 5037-5042.
33. Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N and Old LJ. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001; 92: 856-860.
34. Li FQ, Yang AL, Miao JW, Zhang CH, Wu B and Zhang XH. [Preparation and characterization of the monoclonal antibody against human sperm protein 17]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2006; 22: 638-640.
35. Wen Y, Richardson RT, Widgren EE and O'Rand MG. Characterization of Sp17: a ubiquitous three domain protein that binds heparin. Biochem J 2001; 357: 25-31.
36. Lacy HM and Sanderson RD. Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell-cell adhesion. Blood 2001; 98: 2160-2165.
37. Zhang Y, Wang Z, Robinson WR and Lim SH. Combined real time PCR and immunohistochemical evaluation of sperm protein 17 as a cancer-testis antigen. Eur J Haematol 2004; 73: 280-284.
38. Zhang WM, Xiao G, Zhang M, Guo AL, Dong Y and Wen JM. [Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma]. Zhonghua Bing Li Xue Za Zhi 2005; 34: 202-205.